• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Regular review: tumour markers in malignancies.

作者信息

Lindblom A, Liljegren A

机构信息

Department of Clinical Genetics, Karolinska Hospital, S171 76 Stockholm, Sweden.

出版信息

BMJ. 2000 Feb 12;320(7232):424-7. doi: 10.1136/bmj.320.7232.424.

DOI:10.1136/bmj.320.7232.424
PMID:10669448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1117546/
Abstract
摘要

相似文献

1
Regular review: tumour markers in malignancies.
BMJ. 2000 Feb 12;320(7232):424-7. doi: 10.1136/bmj.320.7232.424.
2
The diagnostic value of beta-catenin immunohistochemistry.β-连环蛋白免疫组织化学的诊断价值
Adv Anat Pathol. 2005 Nov;12(6):350-6. doi: 10.1097/01.pap.0000194628.58501.71.
3
Comparing breast biomarker status between routine immunohistochemistry and FISH studies and Oncotype DX testing, a study of 610 cases.比较常规免疫组化和 FISH 研究与 Oncotype DX 检测的乳腺生物标志物状态，一项 610 例病例的研究。
Breast J. 2018 Nov;24(6):889-893. doi: 10.1111/tbj.13110. Epub 2018 Sep 19.
4
Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray.通过免疫层析结合反相裂解物微阵列技术测量基于组织的生物标志物。
Clin Cancer Res. 2006 Apr 15;12(8):2463-7. doi: 10.1158/1078-0432.CCR-05-1479.
5
AMACR: an emerging diagnostic and prognostic tool in systemic malignancies.α-甲基酰基辅酶A消旋酶：一种用于全身性恶性肿瘤的新兴诊断和预后评估工具。
Int Urol Nephrol. 2013 Apr;45(2):439-40. doi: 10.1007/s11255-013-0393-3. Epub 2013 Feb 8.
6
Pathology and the Internet.
Adv Anat Pathol. 2003 Jul;10(4):234-5. doi: 10.1097/00125480-200307000-00007.
7
Equivalency of RT-PCR and immunohistochemistry: fact or factoid.
Breast Cancer Res Treat. 2009 Jul;116(1):145-7. doi: 10.1007/s10549-008-0176-1. Epub 2008 Sep 12.
8
Promises and limitations of biomarkers.生物标志物的前景与局限
Recent Results Cancer Res. 2009;181:55-9. doi: 10.1007/978-3-540-69297-3_6.
9
Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors.常规组织学、免疫组织化学、逆转录聚合酶链反应及荧光原位杂交技术在尤因家族性肿瘤诊断中的对比分析
Arch Pathol Lab Med. 2006 Dec;130(12):1813-8. doi: 10.5858/2006-130-1813-CAORHI.
10
[The future of molecular markers in cancer: towards a tailored treatment].[癌症分子标志物的未来：迈向个性化治疗]
Med Clin (Barc). 2009 Apr 18;132(14):549-50. doi: 10.1016/j.medcli.2008.12.019. Epub 2009 Apr 14.

引用本文的文献

1
Evaluation of the relationship between the expression of AgNOR and Ki67 with the recurrence rate in central granulomatous giant cell lesions: A case-control.AgNOR 和 Ki67 的表达与中央性结节性巨细胞病变的复发率之间关系的评估：病例对照研究。
Clin Exp Dent Res. 2024 Apr;10(2):e870. doi: 10.1002/cre2.870.
2
FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1.用于将细胞毒性药物靶向递送至过表达FGFR1的癌细胞的FGF2衍生肽抗体F2-MMAE偶联物
Cancers (Basel). 2020 Oct 15;12(10):2992. doi: 10.3390/cancers12102992.
3
Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies.纤维肉瘤的当前诊断与治疗——未来治疗靶点与策略的展望
Oncotarget. 2017 Aug 10;8(61):104638-104653. doi: 10.18632/oncotarget.20136. eCollection 2017 Nov 28.
4
Osteopontin -- a promising biomarker for cancer therapy.骨桥蛋白——一种有前景的癌症治疗生物标志物。
J Cancer. 2017 Jul 15;8(12):2173-2183. doi: 10.7150/jca.20480. eCollection 2017.
5
The diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the sera of patients with brain tumor.酒精脱氢酶（ADH）同工酶及醛脱氢酶（ALDH）检测对脑肿瘤患者血清的诊断价值
Arch Med Sci. 2017 Mar 1;13(2):346-352. doi: 10.5114/aoms.2017.65366. Epub 2017 Jan 23.
6
Diagnostic value of circulating chromogranin a for neuroendocrine tumors: a systematic review and meta-analysis.循环嗜铬粒蛋白 A 对神经内分泌肿瘤的诊断价值：系统评价和荟萃分析。
PLoS One. 2015 Apr 20;10(4):e0124884. doi: 10.1371/journal.pone.0124884. eCollection 2015.
7
The activity of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in the sera of patients with brain cancer.脑癌患者血清中乙醇脱氢酶（ADH）同工酶和乙醛脱氢酶（ALDH）的活性。
Neurochem Res. 2014 Dec;39(12):2313-8. doi: 10.1007/s11064-014-1402-3. Epub 2014 Oct 10.
8
The use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancer.利用敏感的化学抗体进行诊断：检测乳腺癌中的低水平 EpCAM。
PLoS One. 2013;8(2):e57613. doi: 10.1371/journal.pone.0057613. Epub 2013 Feb 27.
9
Studies of biochemical parameters in breast cancer with and without metastasis.伴有和不伴有转移的乳腺癌生化参数研究。
Indian J Clin Biochem. 2004 Jan;19(1):71-5. doi: 10.1007/BF02872394.
10
The gene expression profiles of canine mammary cancer cells grown with carcinoma-associated fibroblasts (CAFs) as a co-culture in vitro.体外共培养癌相关成纤维细胞（CAFs）的犬乳腺癌细胞的基因表达谱。
BMC Vet Res. 2012 Mar 27;8:35. doi: 10.1186/1746-6148-8-35.

本文引用的文献

1
PSA screening said to reduce prostate-cancer deaths, or does it?
Lancet. 1998 May 23;351(9115):1563. doi: 10.1016/S0140-6736(05)61131-2.
2
HER-2/neu as a predictive marker of response to breast cancer therapy.HER-2/neu作为乳腺癌治疗反应的预测标志物。
Breast Cancer Res Treat. 1998;52(1-3):65-77. doi: 10.1023/a:1006111117877.
3
Molecular staging of malignant melanoma: correlation with clinical outcome.恶性黑色素瘤的分子分期：与临床结局的相关性
JAMA. 1998 Oct 28;280(16):1410-5. doi: 10.1001/jama.280.16.1410.
4
Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.利用存档石蜡包埋组织通过巢式逆转录聚合酶链反应检测黏液样和圆形细胞脂肪肉瘤中的 TLS/FUS-CHOP 融合转录本
Diagn Mol Pathol. 1998 Apr;7(2):96-101. doi: 10.1097/00019606-199804000-00006.
5
The sentinel node in breast cancer--a multicenter validation study.乳腺癌前哨淋巴结——一项多中心验证研究。
N Engl J Med. 1998 Oct 1;339(14):941-6. doi: 10.1056/NEJM199810013391401.
6
New tumor markers of testis cancer.睾丸癌的新型肿瘤标志物。
Urol Clin North Am. 1998 Aug;25(3):365-73. doi: 10.1016/s0094-0143(05)70027-6.
7
Prognostic factors in colorectal cancer. Literature review for clinical application.结直肠癌的预后因素。临床应用的文献综述。
Dis Colon Rectum. 1998 Aug;41(8):1033-49. doi: 10.1007/BF02237397.
8
Micrometastases and survival in stage II colorectal cancer.II期结直肠癌中的微转移与生存情况
N Engl J Med. 1998 Jul 23;339(4):223-8. doi: 10.1056/NEJM199807233390403.
9
The value of tumor markers in colorectal cancer.肿瘤标志物在结直肠癌中的价值。
Recent Results Cancer Res. 1998;146:48-55. doi: 10.1007/978-3-642-71967-7_4.
10
Utilization of polymerase chain reaction technology in the detection of solid tumors.聚合酶链反应技术在实体瘤检测中的应用
Cancer. 1998 Apr 15;82(8):1419-42. doi: 10.1002/(sici)1097-0142(19980415)82:8<1419::aid-cncr1>3.0.co;2-4.